Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

DXR Raman Microscope

By Drug Discovery Trends Editor | March 11, 2008

Thermo Fisher DXR Raman MicroscopeThermo Fisher Scientific Inc. launched its new Thermo Scientific DXR Raman microscope. The instrument is designed specifically to help non-specialist users achieve rapid sampling and analysis of particles, down to one-micron spatial resolution. The DXR Raman microscope is equipped with fully integrated, pre-aligned components for fast and easy field installation and configuration. This flexible, innovative system utilizes several patented features to automate and simplify the steps an expert would go through to optimize a measurement. Interchangeable SMART components require no operator adjustment and ensure automated system configuration. Patented auto alignment and auto calibration ensure reliable results. Furthermore, the microscope utilizes the Thermo Scientific ValPro complete system validation package, allowing for compliance with cGMP and FDA regulatory requirements.

The DXR Raman microscope is designed to make the Raman technique accessible to a much wider audience by replacing manual adjustments with system intelligence and automation. The DXR Raman microscope brings the power of Raman microscopy to academic studies, for characterization of geological specimens.

www.thermofisher.com 

This article was published in Drug Discovery & Development magazine: Vol. 11, No. 3, March, 2008, pp. 40.


Filed Under: Drug Discovery

 

Related Articles Read More >

Sanders, King target DTC pharma ads but the industry worries more about threats to its $2B R&D model
Zoliflodacin wins FDA nod for treatment of gonorrhea
FDA approved ENFLONSIA for the prevention of RSV in Infants
First clinical study results of Dupixent for atopic dermatitis in patients with darker skin tones 
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE